|
|
|
Volumn 2, Issue 3, 1995, Pages 687-706
|
|
Antibody-Directed Enzyme Prodrug Therapy (ADEPT): A targeting strategy in cancer chemotherapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALKALINE PHOSPHATASE;
ALPHA GALACTOSIDASE;
ANTIBODY CONJUGATE;
BETA GLUCURONIDASE;
BETA LACTAMASE;
CARBOXYPEPTIDASE A;
CARBOXYPEPTIDASE G2;
CEPHALOSPORIN DERIVATIVE;
CYTOSINE DEAMINASE;
DOXORUBICIN DERIVATIVE;
DOXORUBICIN PHOSPHATE;
ENZYME;
EPIRUBICIN GLUCURONIDE;
ETOPOFOS;
FLUCYTOSINE;
GLUTAMIC ACID DERIVATIVE;
MELPHALAN DERIVATIVE;
METHOTREXATE ALPHA ALANINE;
MITOMYCIN C DERIVATIVE;
NITROREDUCTASE;
PENICILLIN AMIDASE;
PENICILLIN V AMIDASE;
PRODRUG;
UNCLASSIFIED DRUG;
ANTIBODY DIRECTED ENZYME PRODRUG THERAPY;
CANCER;
CONJUGATION;
DRUG ACTIVATION;
DRUG DESIGN;
DRUG TARGETING;
ENZYME BINDING;
HUMAN;
IMMUNOTHERAPY;
REVIEW;
|
|
EID: 0028972656
PISSN: 09298673
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (39)
|
|
References (0)
|
